Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CDSCO flags 22 Drug Samples As Not Of Standard Quality

Ruchika Sharma14 Sept 2020 6:19 PM IST

New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 22 drug samples as 'Not of Standard Quality'...

Gilead to acquire Immunomedics for over USD 20 billion

Ruchika Sharma14 Sept 2020 4:25 PM IST

US: Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would...

Indoco Remedies Blood-thinner Apixaban gets USFDA green flag

Ruchika Sharma14 Sept 2020 3:02 PM IST

It is used for patients with health problems caused by a blood clot.

Indoco Remedies Blood-thinner Apixaban gets USFDA green flag

Ruchika Sharma14 Sept 2020 3:02 PM IST

It is used for patients with health problems caused by a blood clot.

AstraZeneca restarts COVID-19 vaccine trials in UK

Ruchika Sharma14 Sept 2020 1:00 PM IST

It added that safety reviewers had recommended to Britain's Medicines Health Regulatory Authority(MHRA) that it was safe to resume the British trials.

Zydus Wellness to focus on three-pronged strategy to drive growth

Ruchika Sharma14 Sept 2020 11:30 AM IST

New Delhi: Consumer wellness firm Zydus Wellness has said it will take a three-pronged strategy to drive growth going forward.As a part of the...

CCI approves acquisition of 20 percent stake in Piramal Pharma by Carlyle Group

Ruchika Sharma13 Sept 2020 10:15 AM IST

The estimated equity capital investment for Carlyle's 20 percent stake in Piramal Pharma would amount to around USD 490 million, it said.

Granules India Dexmethylphenidate HCl ER capsules get USFDA approval to treat ADHD

Ruchika Sharma13 Sept 2020 10:00 AM IST

Hyderabad: Drugmaker Granules India has recently announced that the company's US subsidiary has received marketing approval from the U.S. Health...

COVID-19: Indian Institute of Integrative Medicine undertakes clinical trials of 3-4 drug formulations

Ruchika Sharma13 Sept 2020 9:45 AM IST

"If they (all the requisite trials) are successful, we can make medicines soon available", Reddy said.

Potential COVID vaccine: NII study conducted on mice show positive results

Ruchika Sharma13 Sept 2020 9:30 AM IST

New Delhi: An immunogenicity study conducted on mice for the coronavirus vaccine candidate being developed by the National Institute of...

Zydus Cadila cancer treatment injection Doxorubicin Hydrochloride Liposome gets USFDA okay

Ruchika Sharma12 Sept 2020 9:45 AM IST

Liposomal doxorubicin is a chemotherapeutic agent that is used alone or with other treatments/medications to treat certain types of cancer such as...

COVID-19: Hindustan Syringes ramps up production to meet surged demand

Ruchika Sharma11 Sept 2020 1:52 PM IST

Hindustan Syringes said it is increasing its output of auto-disable devices(which prevent re-use) from 700 million a year to one billion by 2021 to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok